Hypertriglyceridemia.
Acute pancreatitis
Angiopoietin-like protein 3
Apolipoprotein C3
Cardiovascular disease
Chylomicronemia
Hypertriglyceridemia
Lipoprotein lipase
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
entrez:
13
8
2022
pubmed:
14
8
2022
medline:
17
8
2022
Statut:
ppublish
Résumé
Mild to moderate hypertriglyceridemia usually results from multiple small-effect variants in genes that control triglyceride metabolism. Hypertriglyceridemia is a critical component of the metabolic syndrome but can also occur secondary to several other conditions or drugs. Hypertriglyceridemia frequently is associated with an increased risk of cardiovascular disease (CVD). Statins are the mainstay of CVD prevention in hypertriglyceridemia, but eicosapentaenoic ethyl esters should be added in very-high-risk individuals. Although fibrates lower triglyceride levels, their role in CVD prevention remains unclear. Familial partial lipodystrophy is another relatively rare cause, although its true incidence is unknown.
Identifiants
pubmed: 35963627
pii: S0889-8529(22)00025-1
doi: 10.1016/j.ecl.2022.02.010
pii:
doi:
Substances chimiques
Triglycerides
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
539-555Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.